SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001501134-23-000072
Filing Date
2023-08-23
Accepted
2023-08-23 08:12:49
Documents
16
Period of Report
2023-08-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvta-20230822.htm   iXBRL 8-K 38191
2 EX-4.1 exhibit41formofnewnotes.htm EX-4.1 40057
3 EX-10.1 exhibit101-exchangeagreeme.htm EX-10.1 165214
4 EX-10.2 exhibit102-firstsupplement.htm EX-10.2 42168
8 nvta-20230822_g1.jpg GRAPHIC 36208
  Complete submission text file 0001501134-23-000072.txt   554348

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvta-20230822.xsd EX-101.SCH 1901
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvta-20230822_lab.xml EX-101.LAB 23834
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvta-20230822_pre.xml EX-101.PRE 12508
10 EXTRACTED XBRL INSTANCE DOCUMENT nvta-20230822_htm.xml XML 2713
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 231195198
SIC: 8071 Services-Medical Laboratories